SCHEMBL6061022

SCHEMBL6061022

Nc1c(C(=O)c2ccccc2O)oc2ccc(Cl)cc12.Nc1c(C(=O)c2ccccc2OCc2ccccc2)oc2ccc(Cl)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
PTGER1 P34995 2/20 0.43
RAB9A P51151 4/20 0.42
NPC1 O15118 3/20 0.42
MCL1 Q07820 3/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ADORA2A P29274 1/20 0.40
CASP1 P29466 1/20 0.40
KMT2A Q03164 1/20 0.40
EDNRA P25101 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5026875 0.95 KDM4E (0.51) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL5025590 0.85 KDM4E (0.62) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL5023109 0.83 KDM4E (0.55) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL14277067 0.80 KDM4E (0.52) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL6957797 0.74 PTGER1 (0.58) KDM4EPTGER1NPC1CYP2C9KMT2A
SCHEMBL5023683 0.73 MAPT (0.50) KDM4EALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL16795004 0.73 NPC1 (0.71) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL7214882 0.73 MAOB (0.47) RAB9ANPC1
SCHEMBL15107055 0.71 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL5016722 0.71 KDM4E (0.60) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697336-A2 AROYLFURANES AND AROYLTHIOPHENES SUITABLE FOR THE TREATMENT OF CANCER Basilea Pharmaceutica AG (CH) 2006-09-06 EP disclosed
WO-2005061476-A2 AROYLFURANES AND AROYLTHIOPHENES BASILEA PHARMACEUTICA AG (CH) 2005-07-07 WO disclosed